A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.
暂无分享,去创建一个
A. Keshavarzian | L. Mayer | F. Cominelli | P. Stang | R. Hegedus | B. Salzberg | R. Diamond | J. Hain | D. Zelinger | M. Brand | J. Watson | W. Finkelstein | J. Cappa | U. Campbell | M. Garone | C. Lane